287 related articles for article (PubMed ID: 35074332)
1. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic.
El-Shabasy RM; Nayel MA; Taher MM; Abdelmonem R; Shoueir KR; Kenawy ER
Int J Biol Macromol; 2022 Apr; 204():161-168. PubMed ID: 35074332
[TBL] [Abstract][Full Text] [Related]
2. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
Kannan S; Shaik Syed Ali P; Sheeza A
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
[TBL] [Abstract][Full Text] [Related]
3. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
5. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
[TBL] [Abstract][Full Text] [Related]
6. Omicron variant in COVID-19 current pandemic: a reason for apprehension.
Kamble P; Daulatabad V; Patil R; John NA; John J
Horm Mol Biol Clin Investig; 2023 Mar; 44(1):89-96. PubMed ID: 36064193
[TBL] [Abstract][Full Text] [Related]
7. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
8. The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape.
Tian D; Sun Y; Zhou J; Ye Q
Front Immunol; 2021; 12():751778. PubMed ID: 34917076
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
10. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
Malik JA; Ahmed S; Mir A; Shinde M; Bender O; Alshammari F; Ansari M; Anwar S
J Infect Public Health; 2022 Feb; 15(2):228-240. PubMed ID: 35042059
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time-course study - potential challenge for vaccines and therapies.
Weber S; Ramirez CM; Weiser B; Burger H; Doerfler W
EMBO Mol Med; 2021 Jun; 13(6):e14062. PubMed ID: 33931941
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
13. Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe.
Thakur V; Bhola S; Thakur P; Patel SKS; Kulshrestha S; Ratho RK; Kumar P
Infection; 2022 Apr; 50(2):309-325. PubMed ID: 34914036
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
Yang W; Shaman J
medRxiv; 2021 Nov; ():. PubMed ID: 34845460
[TBL] [Abstract][Full Text] [Related]
15. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
Elife; 2022 May; 11():. PubMed ID: 35587653
[TBL] [Abstract][Full Text] [Related]
16. SARS-COV-2 Variants: Differences and Potential of Immune Evasion.
Hirabara SM; Serdan TDA; Gorjao R; Masi LN; Pithon-Curi TC; Covas DT; Curi R; Durigon EL
Front Cell Infect Microbiol; 2021; 11():781429. PubMed ID: 35118007
[TBL] [Abstract][Full Text] [Related]
17. The first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2.
Wassenaar TM; Wanchai V; Buzard G; Ussery DW
FEMS Microbiol Rev; 2022 May; 46(3):. PubMed ID: 35076068
[TBL] [Abstract][Full Text] [Related]
18. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
19. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.
Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H
Front Public Health; 2022; 10():915363. PubMed ID: 35859775
[TBL] [Abstract][Full Text] [Related]
20. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
Wang L; Cheng G
J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
